RxDoctor Payments Data

Kristen Kivlen, PA

Physician Assistant · Berlin, VTNPI 1174074116

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Abbott at 28.1% of the total. Reporting peaked in 2021 at $229 and has fallen 91.7% since, to $19 in 2023. Among physician assistant clinicians in VT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$266in general payments, 2019–2025

Across 12 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$75
  • Stryker$62
  • Biodelivery Sciences International, Inc.$43
  • Globus Medical$29
  • AstraZeneca$22
  • Scilex Pharmaceuticals Inc.$19
  • plus $17 from 1 others

What the payments were for

  • Food & beverage$266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$266 in reported general payments places this provider in the 90th percentile of 274 physician assistant providers in Vermont.

See all physician assistant providers in Vermont

Medicare billing

Part B allowed, 2024
$68,780
Medicare patients
364
Services billed
705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin114$1,292
Pregabalin45$1,003
Duloxetine Hcl32$682
Lidocaine14$556
Baclofen60$517
Methocarbamol11$129
Cyclobenzaprine Hcl14$77
Tizanidine Hcl12$77
Meloxicam29$42
Diazepam24$15

Paid to pharmacies, not to this prescriber.

Other physician assistant in Berlin

See the full list for Vermont

Where these figures come from

Is this you, or does something look wrong? →